½ÃÀ庸°í¼­
»óǰÄÚµå
1587370

ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå : À¯¹æ CAD ¿µ»ó ¾ç½Ä, ¿µ»ó ¾ç½Ä, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Computer Aided Detection Market by Breast CAD Imaging Modalities (Magnetic Resonance Imaging, Mammography, Nuclear Imaging), Imaging Modalities (Computed Tomography, Nuclear Medicine Imaging, X-Ray Imaging), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀåÀº 2023³â¿¡ 8¾ï 5,800¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 9¾ï 9,650¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2030³â¿¡´Â CAGR16.23%·Î 24¾ï 5,954¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­(CAD) ½ÃÀåÀº ¿¢½º·¹ÀÌ, À¯¹æÃÔ¿µ, MRI, CT¿Í °°Àº ÀÇ·á ½ºÄµ¿¡¼­ ÀÌ»ó ¡Èĸ¦ ½Äº°ÇÏ°í Æò°¡Çϱâ À§ÇØ Ã·´Ü ¾Ë°í¸®ÁòÀ» Ȱ¿ëÇÏ´Â µ¥ ÁßÁ¡À» µÐ ÀÇ·á ¿µ»ó ¹× Áø´Ü ºÐ¾ßÀÇ Çõ½Å ºÐ¾ßÀÔ´Ï´Ù. CAD ½Ã½ºÅÛÀÇ Çʿ伺Àº ¸¸¼º Áúȯ Áõ°¡¿Í Á¶±â Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä·Î ÀÎÇØ °­Á¶µÇ°í ÀÖÀ¸¸ç, CAD ½Ã½ºÅÛÀº ºÐ¼®ÀÇ Á¤È®¼º°ú ¼Óµµ Çâ»óÀ» ÅëÇØ À̸¦ Å©°Ô Áö¿øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä ÀÀ¿ë ºÐ¾ß´Â Á¾¾çÇÐ, ½ÉÇ÷°ü, ½Å°æ ¿µ»ó Áø´ÜÀ̸ç, ÃÖÁ¾ »ç¿ëÀÚ´Â º´¿ø, ¿¬±¸ ±â°ü, Áø´Ü¼¾ÅÍ µîÀÔ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº ¿µ»ó ¾ç½ÄÀÇ ±â¼ú ¹ßÀü, ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ¿ø°Ý ÀÇ·áÀÇ Ã¤Åà Áõ°¡ÀÔ´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ¸ÂÃá CAD ¼Ö·ç¼Ç °³¹ß, ºòµ¥ÀÌÅÍ ºÐ¼® Ȱ¿ë, º¸´Ù Á¢±ÙÇϱ⠽¬¿î ¼Ö·ç¼ÇÀ» À§ÇÑ Å¬¶ó¿ìµå ±â¹Ý ¹èÆ÷ ¸ðµ¨¿¡¼­ ãÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª CAD ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë, ƯÁ¤ Áö¿ª¿¡¼­ÀÇ ³·Àº ÀÎÁöµµ, ƯÈ÷ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× ¼ÒÇÁÆ®¿þ¾î °ËÁõ°ú °ü·ÃµÈ ±ÔÁ¦ À庮°ú °°Àº Á¦¾à¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤È®ÇÑ Å½Áö¸¦ À§ÇÑ °íǰÁú À̹ÌÁö µ¥ÀÌÅÍ¿¡ ´ëÇÑ ÀÇÁ¸µµµµ ¿©ÀüÈ÷ ¹®Á¦Á¡À¸·Î ³²¾ÆÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ±Øº¹Çϱâ À§Çؼ­´Â ºñ¿ë Àý°¨, »óÈ£¿î¿ë¼º, ±âÁ¸ ½Ã½ºÅÛ°úÀÇ ÅëÇÕ ¿ëÀ̼º µîÀÇ ºÐ¾ß¿¡¼­ ´õ ¸¹Àº Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù. ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÇнÀÇÏ°í °³¼±ÇÏ´Â ÀûÀÀÇü ¾Ë°í¸®Áò¿¡ ´ëÇÑ ¿¬±¸´Â ºñÁî´Ï½º ¼ºÀåÀÇ ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ½ÃÀå »óȲÀº ¿ªµ¿ÀûÀ̸ç, ºÐ¼® ¿ª·®À» °­È­Çϱâ À§ÇØ AI¸¦ ÅëÇÕÇÏ·Á´Â ¿òÁ÷ÀÓÀÌ °­ÇØÁö°í ÀÖ½À´Ï´Ù. »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º, °­·ÂÇÑ ÈÆ·Ã µ¥ÀÌÅÍ ¼¼Æ®, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Çù¾÷À» ÅëÇÑ ½ÇÁ¦ Çǵå¹éÀ» ¿ì¼±½ÃÇÏ´Â ±â¾÷ÀÌ µÎ°¢À» ³ªÅ¸³¾ ¼ö ÀÖÀ¸¸ç, CAD ½ÃÀåÀÌ °è¼Ó ÁøÈ­ÇÔ¿¡ µû¶ó È®À强°ú À¯¿¬¼ºÀÌ ¶Ù¾î³­ ¼Ö·ç¼Ç¿¡ ÁýÁßÇÏ´Â °ÍÀÌ »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀÔ´Ï´Ù. »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇϰí Áö¼ÓÀûÀÎ ¼ºÀåÀ» º¸ÀåÇϱâ À§Çؼ­´Â È®À强°ú À¯¿¬¼ºÀ» °®Ãá ¼Ö·ç¼Ç¿¡ ÁýÁßÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 8¾ï 5,800¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 9¾ï 9,650¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 24¾ï 5,954¸¸ ´Þ·¯
CAGR(%) 16.23%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÄÄÇ»ÅÍ Áö¿ø °¨Áö ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼ºÁúȯ Áõ°¡¿Í °Ç°­°ËÁø¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡
    • ÃÊÀ½ÆÄ ¹× ÀÚ±â°ø¸í¿µ»ó ±â¹ýÀ» ÀÌ¿ëÇÑ CAD »ç¿ë Áõ°¡
    • ÀÇ·á°ü±¤¿¡ ÄÄÇ»ÅÍ Áö¿ø °¨Áö ±â¼ú µµÀÔ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • »õ·Î¿î ½Ã½ºÅÛ Á¦Á¶ ¹× ±¸¸Å ºñ¿ëÀÇ ³ôÀº ¼öÁØ
  • ½ÃÀå ±âȸ
    • ÷´Ü À¯¹æ¾Ï ¿µ»ó Áø´Ü ±â¼ú °³¹ß
    • CAD¿¡¼­ ÀΰøÁö´ÉÀÇ ÁøÈ­¸¦ ÇâÇÑ ±â¼ú ¹ßÀü
  • ½ÃÀå °úÁ¦
    • ³ôÀº À§¾ç¼º °ËÃâ·ü

Portre's Five Forces: ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÏ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÄÄÇ»ÅÍ Áö¿ø °¨Áö ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

PESTLE ºÐ¼® : ÄÄÇ»ÅÍ Áö¿ø °¨Áö ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÄÄÇ»ÅÍ Áö¿ø °¨Áö ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÄÄÇ»ÅÍ Áö¿ø °¨Áö ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

ÄÄÇ»ÅÍ Áö¿ø °¨Áö ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÄÄÇ»ÅÍ Áö¿ø °¨Áö ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× °æ·Î¸¦ ±×¸®´Ù.

ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå : À¯¹æ CAD ¿µ»ó Áø´Ü Àåºñº°

  • ÀÚ±â°ø¸í¿µ»ó
  • ¸¾¸ð±×·¡ÇÇ
  • ÇÙ¿µ»ó
  • Tomosynthesis
  • ÃÊÀ½ÆÄ ¿µ»ó Áø´Ü

Á¦7Àå ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå : ¿µ»ó Áø´Ü¹ýº°

  • ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ
  • ÇÙÀÇÇÐ ¿µ»ó Áø´Ü
  • X¼± ¿µ»ó

Á¦8Àå ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå : ¿ëµµº°

  • »À¾Ï
  • À¯¹æ¾Ï
  • °áÀå
  • °£¾Ï
  • Æó¾Ï
  • ½Å°æÇÐ
  • Àü¸³¼±¾Ï

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÄÄÇ»ÅÍ º¸Á¶ °ËÃâ(CAD) ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Agfa-Gevaert N.V.
  • Canon Medical Systems Corporation
  • EDDA Technology, Inc.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • International Business Machines Corporation
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Median Technologies
  • Riverain Technologies LLC
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
LSH

The Computer Aided Detection Market was valued at USD 858.00 million in 2023, expected to reach USD 996.50 million in 2024, and is projected to grow at a CAGR of 16.23%, to USD 2,459.54 million by 2030.

The Computer Aided Detection (CAD) market is an innovative segment within medical imaging and diagnostics, focusing on leveraging advanced algorithms to identify and evaluate abnormalities in medical scans such as X-rays, mammograms, MRIs, and CTs. The necessity for CAD systems is underscored by the increasing global burden of chronic diseases and the demand for early diagnosis, which CAD systems can significantly aid through enhanced accuracy and speed of analysis. The primary applications span oncology, cardiovascular, and neurological imaging, with end-users including hospitals, research institutions, and diagnostic centers. Market growth is chiefly driven by technological advancements in imaging modalities, integration of artificial intelligence and machine learning, and the increasing adoption of telemedicine. Emerging opportunities lie in the development of CAD solutions tailored for personalized medicine, leveraging big data analytics, and cloud-based deployment models for more accessible solutions. However, the market faces limitations such as high costs of CAD systems, limited awareness in certain regions, and regulatory hurdles, especially regarding data privacy and software validation. Additionally, the reliance on high-quality imaging data for accurate detection remains a challenge. To overcome these challenges, further innovation is necessary in the areas of cost reduction, interoperability, and ease of integration with existing systems. Research into adaptive algorithms that can learn and improve over time offers potential for business growth. The market landscape is dynamic, with a strong push towards integrating AI for enhanced analytical capabilities. Companies that prioritize user-friendly interfaces, robust training datasets, and collaboration with healthcare providers for real-world feedback can stand out. As the CAD market continues to evolve, focusing on scalable and flexible solutions will be pivotal in capturing emerging opportunities and ensuring sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 858.00 million
Estimated Year [2024] USD 996.50 million
Forecast Year [2030] USD 2,459.54 million
CAGR (%) 16.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Computer Aided Detection Market

The Computer Aided Detection Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in prevalence of chronic diseases and rising awareness regarding health check-ups
    • Rising use of CAD with ultrasound and magnetic resonance imaging modalities
    • Adoption of computer-aided detection in medical tourism
  • Market Restraints
    • High production and purchasing cost for new systems
  • Market Opportunities
    • Development of advanced breast cancer imaging techniques
    • Technological advances for evolution of artificial intelligence in CAD
  • Market Challenges
    • High rate of false-positive detections

Porter's Five Forces: A Strategic Tool for Navigating the Computer Aided Detection Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Computer Aided Detection Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Computer Aided Detection Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Computer Aided Detection Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Computer Aided Detection Market

A detailed market share analysis in the Computer Aided Detection Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Computer Aided Detection Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Computer Aided Detection Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Computer Aided Detection Market

A strategic analysis of the Computer Aided Detection Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Computer Aided Detection Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert N.V., Canon Medical Systems Corporation, EDDA Technology, Inc., Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hitachi Ltd., Hologic, Inc., iCAD, Inc., International Business Machines Corporation, Koninklijke Philips N.V., McKesson Corporation, Median Technologies, Riverain Technologies LLC, Samsung Medison Co., Ltd., Shimadzu Corporation, and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Computer Aided Detection Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Breast CAD Imaging Modalities, market is studied across Magnetic Resonance Imaging, Mammography, Nuclear Imaging, Tomosynthesis, and Ultrasound Imaging.
  • Based on Imaging Modalities, market is studied across Computed Tomography, Nuclear Medicine Imaging, and X-Ray Imaging.
  • Based on Application, market is studied across Bone Cancer, Breast Cancer, Colon, Liver Cancer, Lung Cancer, Neurological, and Prostate Cancer.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of chronic diseases and rising awareness regarding health check-ups
      • 5.1.1.2. Rising use of CAD with ultrasound and magnetic resonance imaging modalities
      • 5.1.1.3. Adoption of computer-aided detection in medical tourism
    • 5.1.2. Restraints
      • 5.1.2.1. High production and purchasing cost for new systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced breast cancer imaging techniques
      • 5.1.3.2. Technological advances for evolution of artificial intelligence in CAD
    • 5.1.4. Challenges
      • 5.1.4.1. High rate of false-positive detections
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Computer Aided Detection Market, by Breast CAD Imaging Modalities

  • 6.1. Introduction
  • 6.2. Magnetic Resonance Imaging
  • 6.3. Mammography
  • 6.4. Nuclear Imaging
  • 6.5. Tomosynthesis
  • 6.6. Ultrasound Imaging

7. Computer Aided Detection Market, by Imaging Modalities

  • 7.1. Introduction
  • 7.2. Computed Tomography
  • 7.3. Nuclear Medicine Imaging
  • 7.4. X-Ray Imaging

8. Computer Aided Detection Market, by Application

  • 8.1. Introduction
  • 8.2. Bone Cancer
  • 8.3. Breast Cancer
  • 8.4. Colon
  • 8.5. Liver Cancer
  • 8.6. Lung Cancer
  • 8.7. Neurological
  • 8.8. Prostate Cancer

9. Americas Computer Aided Detection Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Computer Aided Detection Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Computer Aided Detection Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agfa-Gevaert N.V.
  • 2. Canon Medical Systems Corporation
  • 3. EDDA Technology, Inc.
  • 4. Esaote SpA
  • 5. Fujifilm Holdings Corporation
  • 6. General Electric Company
  • 7. Hitachi Ltd.
  • 8. Hologic, Inc.
  • 9. iCAD, Inc.
  • 10. International Business Machines Corporation
  • 11. Koninklijke Philips N.V.
  • 12. McKesson Corporation
  • 13. Median Technologies
  • 14. Riverain Technologies LLC
  • 15. Samsung Medison Co., Ltd.
  • 16. Shimadzu Corporation
  • 17. Siemens Healthineers AG
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦